Di Feng developed an interest in studying hypertension and kidney disease during college. She received her BS in Pharmaceutical Science from Peking University and Ph.D. in Physiology from Medical College of Wisconsin under the mentorship of Dr. Allen Cowley. During her graduate school, she used animal models to identify a new gene contributing to salt-sensitive hypertension as a result of kidney dysfunction. She is now furthering her training as a post doctoral fellow in Dr. Martin Pollak’s lab by studying the signaling and regulatory pathways of ACTN4, a cytoskeleton protein that is associated with chronic kidney disease in humans. Her ultimate goal is to identify targets and develop novel therapies for patients with hypertension and kidney disease.